Capsules

Share

Program Content

Activities

  • CAPELLA: LEN in MDR HIV at Wk 104
    CAPELLA: Wk 104 Results With Long-Acting Subcutaneous Lenacapavir in Persons Living With Multidrug-Resistant HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 19, 2023

    View Activity
  • BRIGHTE Wk 240 Update
    BRIGHTE Update: Wk 240 Results From Phase III Study of Fostemsavir + OBT in Heavily Treatment–Experienced People on Failing ART Regimens
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 19, 2023

    View Activity
  • HBV Reactivation After ART Switch
    HBV Reactivation After Switch to ART Lacking HBV Activity: Results in Persons With Hepatitis B Core Antibody Positivity
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 20, 2023

    View Activity
  • GLP-1 RAs and Weight Loss in HIV
    Impact of GLP-1 Receptor Agonists on Weight Loss in People Living With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 20, 2023

    View Activity
  • SC LEN PK by Administration Site
    Clinical Pharmacokinetics of Subcutaneous Lenacapavir: Impact of Administration Sites
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 23, 2023

    View Activity
  • OPERA: CAB + RPV by BMI
    OPERA Subset: Effectiveness of LA CAB + RPV in Virologically Suppressed, Treatment-Experienced People Living With HIV, Stratified by BMI
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 23, 2023

    View Activity
  • DOR Resistance in HIV
    Real-world Prevalence and Impact of DOR-Related Resistance Mutations Among NNRTI-Naive and Experienced Persons Living With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 23, 2023

    View Activity
  • Representation LA ART Studies
    Representation of Women, Black People and People of Color, and Older Adults in Studies Evaluating Long-Acting Antiretroviral Therapy
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 25, 2023

    View Activity

Provided by

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare